Elimination of chronic viral hepatitis C in correctional health.
10.4103/singaporemedj.SMJ-2025-161
- Author:
Rahul KUMAR
1
;
Yu Jun WONG
1
;
Jessica TAN
1
Author Information
1. Department of Gastroenterology and Hepatology, Changi General Hospital, Singapore.
- Publication Type:Review
- Keywords:
Correctional health;
HCV;
Singapore;
micro-elimination
- MeSH:
Humans;
Singapore;
Antiviral Agents/therapeutic use*;
Hepatitis C, Chronic/epidemiology*;
Prisons;
Prisoners;
Disease Eradication;
Cost-Benefit Analysis;
Hepacivirus;
Correctional Facilities
- From:Singapore medical journal
2025;66(Suppl 1):S70-S74
- CountrySingapore
- Language:English
-
Abstract:
Correctional facilities are a major hub of hepatitis C virus (HCV), with rates far higher than those observed in the general population. Once considered an intractable crisis, the current situation offers a unique opportunity. The advent of direct-acting antivirals has changed the HCV treatment landscape, making its elimination possible. This review summarises the scientific evidence and progress towards HCV elimination in correctional health systems. It outlines the evolution of 'test-and-treat' models, assesses micro-elimination success worldwide, especially in Singapore, and highlights collaborative efforts between Changi General Hospital and Singapore Prison Services. Their implementation of HCV treatment guidelines serves as a key case study in this context. This review also analyses the various barriers - structural, financial, clinical and logistical - that hinder progress. It consolidates strong evidence that prison-based HCV treatment is cost-effective, promotes health equity, supports the World Health Organization 2030 goals and reduces the societal burden of HCV.
